Learn Details of the Advances in Brain Tumor Treatment Market Forecast and Segments, 2016-2026
- Submitted by: fmiresearch
- Views: 64
- Category: English: Authors
- Date Submitted: 03/21/2016 09:03 PM
- Pages: 3
- Report this Essay
A brain tumor is an abnormal and uncontrolled proliferation of cells in the brain. It can be benign or malignant. Brain tumor arises from brain tissue and rarely spreads. The tumor eventually compress and damage other structures in the brain. According to American Brain Tumor Association (ABTA), there are two types of brain tumors - primary and secondary. Primary tumors arises from brain tissue and secondary tumors arises from other parts of the body and spreads to brain. Gliomas are most common type of primary tumors which arises from brain’s glial tissue. Glioblastoma multifome is a fast growing and of higher grade when compared to other tumors. Advanced medications are available to treat the brain tumors. Increasing pharmaceutical R&D spending is expected to provide the lucrative growth for the global brain tumor treatment market over the forecasted period.
Brain Tumor Treatment Market: Drivers and restraints
Increasing incidence of brain tumor (Glioblastoma) is one of the leading factor driving the growth of the market globally. For instance, as per the American Society of Clinical Oncology (ASCO), brain tumor incidence rate growing at 2.6% compared to the last year. An estimated 22,850 cases diagnosed with primary cancerous tumors of the brain in the U.S. Furthermore, increasing geriatric population is also driving the brain tumor market. Increasing consumer awareness regarding the latest technological advancements in therapies, and medications are responsible for the growth of global brain tumor treatment market.
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1302
Brain Tumor Treatment Market: Segmentation
Global Brain Tumor Treatment Market can be segmented as following types
By Product:
• Temozolomide
• Carmustine
• Cisplatin
• Bevacizumab
• Geftinib
• Erlotinib
By End user:
• Hospital Pharmacies
• Ambulatory Surgical Centers
• Individual Pharmacies
Brain Tumor Treatment Market: Overview...
Brain Tumor Treatment Market: Drivers and restraints
Increasing incidence of brain tumor (Glioblastoma) is one of the leading factor driving the growth of the market globally. For instance, as per the American Society of Clinical Oncology (ASCO), brain tumor incidence rate growing at 2.6% compared to the last year. An estimated 22,850 cases diagnosed with primary cancerous tumors of the brain in the U.S. Furthermore, increasing geriatric population is also driving the brain tumor market. Increasing consumer awareness regarding the latest technological advancements in therapies, and medications are responsible for the growth of global brain tumor treatment market.
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1302
Brain Tumor Treatment Market: Segmentation
Global Brain Tumor Treatment Market can be segmented as following types
By Product:
• Temozolomide
• Carmustine
• Cisplatin
• Bevacizumab
• Geftinib
• Erlotinib
By End user:
• Hospital Pharmacies
• Ambulatory Surgical Centers
• Individual Pharmacies
Brain Tumor Treatment Market: Overview...